|
|
 |
|
Viewing report
|
|
 |
 |
25+ Business Development and Innovation Opportunities in Cancer Medicine - 2001
ADIS, Jan 2001, Pages: 300
The objectives of this report are:
- to describe and evaluate the technologies under consideration for cancer treatment - identify late stage, unpartnered licensing opportunities - examine the status of the leading research and development programs - forecast the cancer therapy market by key indication through the year 2010.
It identifies and evaluates over 25+ late stage, unpartnered opportunities in the areas mentioned above.
Customers who bought this item also bought
25+ Business Development and Innovation Opportunities in Diabetes and Related Conditions - Emerging Opportunities to 2010
CNS Drug Licensing: Opportunities, Analysis, Rating and Ranking - A Worldwide Study
Antiviral Drug Licensing Opportunities: Analysis, Rating, and Ranking - A Worldwide Study
Autoimmune/Inflammatory Disease Drug Licensing Opportunities: Analysis, Rating and Ranking - A Worldwide Study
Cancer Therapy US Market Survey: Analysis and Forecast - Technology, Sales and Company Profiles
Drugs of Tomorrow 2001: Diabetes
Cardiology Drug Licensing Opportunities, 2002
Competitive Strategies in Cancer Medicine, 2000
Strategic Perspective 2001: Female Cancers - Optimizing Market Opportunities
Antibacterial: Drug Licensing Opportunities, 2002
Cancer Therapy Worldwide Market Survey: Analysis and Forecast - Technology, Sales and Company Profiles
Drug Delivery 2000: A Key Company and Market Analysis
|
 |
|
|